Seroprevalence of pertussis in Madagascar and implications for vaccination.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
16 11 2020
Historique:
pubmed: 17 11 2020
medline: 26 1 2021
entrez: 16 11 2020
Statut: epublish

Résumé

Pertussis is a highly contagious infectious disease and remains an important cause of mortality and morbidity worldwide. Over the last decade, vaccination has greatly reduced the burden of pertussis. Yet, uncertainty in individual vaccination coverage and ineffective case surveillance systems make it difficult to estimate burden and the related quantity of population-level susceptibility, which determines population risk. These issues are more pronounced in low-income settings where coverage is often overestimated, and case numbers are under-reported. Serological data provide a direct characterisation of the landscape of susceptibility to infection; and can be combined with vaccination coverage and basic theory to estimate rates of exposure to natural infection. Here, we analysed cross-sectional data on seropositivity against pertussis to identify spatial and age patterns of susceptibility in children in Madagascar. A large proportion of individuals surveyed were seronegative; however, there were patterns suggestive of natural infection in all the regions analysed. Improvements in vaccination coverage are needed to help prevent additional burden of pertussis in the country.

Identifiants

pubmed: 33190665
doi: 10.1017/S0950268820002800
pii: S0950268820002800
pmc: PMC7770380
doi:

Substances chimiques

Pertussis Vaccine 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e283

Subventions

Organisme : NLM NIH HHS
ID : DP2 LM013102
Pays : United States
Organisme : Wellcome Trust
ID : 106866/Z/15/Z
Pays : United Kingdom

Références

Epidemiol Infect. 2018 Oct;146(14):1807-1810
pubmed: 29986784
Nat Commun. 2019 Apr 9;10(1):1633
pubmed: 30967543
Expert Rev Vaccines. 2014 Sep;13(9):1081-106
pubmed: 25093268
J Infect. 2014 Jan;68 Suppl 1:S119-24
pubmed: 24103807
Bull World Health Organ. 2009 Jul;87(7):535-41
pubmed: 19649368
Pediatr Infect Dis J. 2015 Apr;34(4):333-8
pubmed: 25764094
Syst Rev. 2015 May 01;4:62
pubmed: 25930111
APMIS. 2009 Nov;117(11):797-807
pubmed: 19845530
Int Health. 2015 Nov;7(6):426-32
pubmed: 25788580
Epidemiol Infect. 2019 Jan;147:e199
pubmed: 31364527
Front Immunol. 2019 Jul 03;10:1344
pubmed: 31333640
Lancet Infect Dis. 2017 Sep;17(9):974-980
pubmed: 28623146
PLoS One. 2012;7(10):e48684
pubmed: 23119090
Vaccine. 2016 Jul 29;34(35):4103-4109
pubmed: 27349841
Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671):
pubmed: 25964453
Lancet Infect Dis. 2003 Jul;3(7):413-8
pubmed: 12837346
Pathog Dis. 2015 Oct;73(7):
pubmed: 26208655
J Med Microbiol. 2016 Jul;65(7):649-657
pubmed: 27075481
Lancet Infect Dis. 2017 Sep;17(9):889-890
pubmed: 28623145
Scand J Infect Dis. 2014 Apr;46(4):280-7
pubmed: 24520981
Heliyon. 2018 Mar 07;4(3):e00563
pubmed: 29560473
J Clin Microbiol. 2000 Feb;38(2):800-6
pubmed: 10655388
Epidemiol Infect. 2005 Feb;133(1):159-71
pubmed: 15724723
Vaccine. 2016 Mar 14;34(12):1423-5
pubmed: 26562318
J Infect Dis. 2002 Aug 1;186(3):415-8
pubmed: 12134239

Auteurs

Solohery L Razafimahatratra (SL)

Bacteriology Experimental Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Amy Wesolowski (A)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Lala Rafetrarivony (L)

Bacteriology Experimental Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Jean-Michel Heraud (JM)

Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Forrest K Jones (FK)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Simon Cauchemez (S)

Mathematical Modelling of Infectious Diseases Unit, Institute Pasteur, UMR 2000, CNRS, Paris, France.

Richter Razafindratsimandresy (R)

Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Sandratana J Raharinantoanina (SJ)

Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Aina Harimanana (A)

Epidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Madagascar.

Jean Marc Collard (JM)

Bacteriology Experimental Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

C J E Metcalf (CJE)

Department of Ecology and Evolutionary Biology and Princeton School of Public and International Affairs, Princeton University, Princeton, NJ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH